News
$GRI Bio (GRI.US)$ GRI Bio (NASDAQ: GRI) Announces FDA Clearance of IND for Lead Program GRI-0621, a Type 1 Invariant NKT ("iNKT") Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis ("IPF")
2 MINUTES AGO, 8:35 AM EST
VIA GLOBENEWSWIRE![]()
2 MINUTES AGO, 8:35 AM EST
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
